** Max Healthcare MAXE.NS falls 6% to 1,025.15 rupees
** Worst performer on Nifty Healthcare Index .NIFHEIN, which is down 1.3%
** MAXE up 3.9% for the week so far
** Hospital chain's Q4 profit, revenue miss analyst estimates
** Revenue per occupied bed grew just 1% YoY, hurt by longer patient stays, treatment mix changes - J.P.Morgan
** MAXE MD says co plans to boost capacity by about 10%
** Macquarie warns street underestimates adverse impact on profitability, reiterates 'underperform' rating
** Seventeen of 22 brokerages rate the stock "buy" or higher; their median PT is 1,254 rupees
** YTD, MAXE down 2.4% vs 7.4% rise in sub-index
($1 = 96.0425 Indian rupees)
(Reporting by Abhinav Parmar in Bengaluru)
((Abhinav.Parmar@thomsonreuters.com;))